Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata affects quality of life more in adolescents than adults.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.